share_log
Benzinga ·  Jul 17 08:05
Longeveron Shares Are Trading Higher After the Company Announced That the FDA Granted Fast Track Designation to Lomecel-B for the Treatment of Mild Alzheimer's Disease
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment